CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
AddLife AB Company Snapshot
AddLife AB operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares AddLife AB with three other miscellaneous service companies in Europe: Galapagos NV of BELGIUM (2020 sales of 530.26 million Euros [US$629.76 million] ), Genus plc of UNITED KINGDOM (£551.40 million [US$757.42 million] of which 54% was Operating Genus PIC), and GW Pharmaceuticals PLC which is also based in UNITED KINGDOM (£407.91 million [US$560.32 million] of which 100% was Novel Therapeutics).

Sales Analysis. AddLife AB reported sales of SEK 5.27 billion (US$611.12 million) for the year ending December of 2020. This represents an increase of 51.6% versus 2019, when the company's sales were SEK 3.48 billion. Sales at AddLife AB have increased during each of the previous five years (and since 2015, sales have increased a total of 399%). Sales of Labtech saw an increase of 62.1% in 2020, from SEK 1.98 billion to SEK 3.21 billion.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
AddLife AB
  Stock Performance Chart for AddLife AB
 
  Stock Data: Recent Stock Performance:
  Current Price (4/1/2021): 161.70
(Figures in Swedish Kronor)
1 Week 2.2%   13 Weeks -6.0%  
4 Weeks 12.3%   52 Weeks 113.8%  
 
AddLife AB Key Data:
  Ticker: ALIF B Country: Sweden
  Exchanges: STO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2020 Sales 5,273,300,000
(Year Ending Jan 2021).
Employees: 1,112
  Currency: Swedish Kronor Market Cap: 18,189,220,180
  Fiscal Yr Ends: December Shares Outstanding: 112,487,447
  Share Type: AKTIE Closely Held Shares: 17,593,425
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.